Lansoprazole

CAS 103577-45-3 32 API suppliersSmall Molecule

Overview

Lansoprazole is a proton pump inhibitor which reduces stomach acid production. It is used primarily in the treatment of gastric ulcers and gastroesophageal reflux disease (GERD).

API suppliers (32)

Suppliers of Lansoprazole evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India16Spain3China2Netherlands1United Kingdom1Brazil1Italy1Taiwan1

Country recorded for 28 of 32 suppliers.

16 of 32 hold a GMP certificate on record in the EU or UK registers

Showing 25 of 32 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (41 approved US products), the latest listed US patent on Lansoprazole expires 21 Apr 2036. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylsulfinyl]-1H-benzimidazole
Canonical SMILES
CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
InChIKey
MJIHNNLFOKEZEW-UHFFFAOYSA-N

Therapeutic areas

GastroenterologyPharmacology
Verified Supplier Partner

Do you supply Lansoprazole? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.